Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 253-257

  Hirayama, Satoshi ^a   Soda, Satoshi ^b   Ito, Yasuki ^c   Matsui, Hiroshi ^c   Ueno, Tsuyoshi ^a   Fukushima, Yoshifumi ^a   Ohmura, Hirotoshi ^a   Hanyu, Osamu ^d   Aizawa, Yoshifusa ^d   Miida, Takashi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA CITY GENERAL HOSPITAL   (Japan)

^c DENKA COMPANY LIMITED   (Japan)

^d NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Hypertriglyceridemia; Postprandial hyperlipidemia; Small dense LDL cholesterol; Type 2 diabetes

Indexed keywords

HEPARIN; LARGE BOUYANT LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SMALL DENSE LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIOASSAY; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 72449187581     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.11.017     Document Type: Article

References (26)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
3. Fukushima H., Sugiyama S., Honda O., et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol 43 (2004) 2219-2224
4. Kannel W.B., D'Agostino R.B., Wilson P.W., Belanger A.J., and Gagnon D.R. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism 5 (1996) 1267-1272
5. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
6. Austin M.A., Mykkanen L., Kuusisto J., et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 92 (1995) 1770-1778
7. de Graaf J.C., Hendriks J.C., Demacker P.N., and Stalenhoef A.F. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after Clofibrate Treatment. Arterioscler Thromb 13 (1993) 712-719
8. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
9. McNamara J.R., Jenner J.L., Li Z., Wilson P.W., and Schaefer E.J. Change in LDL particle size is associated with change in plasma triglyceride concentration. Aterioscler Thromb 12 (1992) 1284-1290
10. Hirano T., Ito Y., Saegusa H., and Yoshino G. A novel and simple method for quantification of small, dense LDL. J Lipid Res 44 (2003) 2193-2220
11. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34 (1995) 1345-1353
12. Miida T., Nakamura Y., Mezaki T., et al. LDL-cholesterol and HDL-cholesterol concentrations decrease during the day. Ann Clin Biochem 39 (2002) 241-249
13. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., and Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260 (1988) 1917-1921
14. Koba S., and Hirano T. Small dense low-density lipoprotein in Japanese men with coronary artery disease. Ann Intern Med 132 (2000) 762
15. Festa A., D'Agostino Jr. R., Mykkänen L., et al. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care 22 (1999) 1688-1693
16. Eriksson J.W., Burén J., Svensson M., Olivecrona T., and Olivecrona G. Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 166 (2003) 359-367
17. Packard C.J. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 31 (2003) 1066-1069
18. Bremner W.F., Sothern R.B., Kanabrocki E.L., et al. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 139 (2000) 164-173
19. Ogita K., Ai M., Tanaka A., et al. Circadian rhythm of serum concentration of small dense low-density lipoprotein cholesterol. Clin Chim Acta 376 (2007) 96-100
20. Rutledge J.C., Woo M.M., Rezai A.A., Curtiss L.K., and Goldberg I.J. Lipoprotein lipase increase lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res 80 (1997) 819-828
21. Laight D.W., Carrier M.J., and Anggard E.E. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev 15 (1999) 274-282
22. Anber V., Griffin B.A., McConnell M., Packard C.J., and Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 124 (1996) 261-271
23. Tribble D.L., Rizzo M., Chair A., Lewis D.M., Blanche P.J., and Krauss R.M. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med 110 (2001) 103-110
24. Galle J., Schneider R., Winner B., et al. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Atherosclerosis 138 (1998) 65-67
25. Lamharzi N., Renard C.B., Kramer F., et al. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions. Diabetes 53 (2004) 3217-3225
26. Sampson M.J., Davies I.R., Braschi S., Ivory K., and Hughes D.A. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with type 2 diabetes. Atherosclerosis 167 (2003) 129-134